MiR-155 is a liposarcoma oncogene that targets casein kinase-1α and enhances β-catenin signaling. - Zhang P; Bill K; Liu J; Young E; Peng T; Bolshakov S; Hoffman A; Song Y; Demicco EG; Terrada DL; Creighton CJ; Anderson ML; et al. (Cancer research, 2012)